Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06175780 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Neoplasms by Histologic Type

Interventions

DRUG: KY-0118
DRUG: KY-0118
DRUG: KY-0118

Sponsor

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.